@article{87fb321652184efab09c166ba88c6d3e,
title = "Genomic epidemiology and temperature dependency of hypermucoviscous Klebsiella pneumoniae in Japan",
abstract = "Klebsiella pneumoniae (Kp) has emerged as a global life-threatening pathogen owing to its multidrug resistance and hypervirulence phenotype. Several fatal outbreaks of carbapenem-resistant hypervirulent Kp have been reported recently. Hypermucoviscosity (HMV) is a phenotype commonly associated with hypervirulence of Kp, which is usually regulated by rmpA or rmpA2 (regulators of the mucoid phenotype). Here, we found that temperature was important in the HMV phenotype of Kp, and the impact of temperature on HMV was not uniform among strains. We investigated the HMV phenotype at 37 °C and room temperature (20–25 °C) in 170 clinically isolated hypermucoviscous Kp strains in Japan and analysed the association between the HMV phenotype, virulence genes and antimicrobial resistance (AMR) genes. String length distribution at different temperatures was correlated with the genomic population of Kp. The strains carrying rmpA/rmpA2 frequently showed the HMV phenotype at 37 °C, while the strains negative for these genes tended to show the HMV phenotype at room temperature. Hypervirulent Kp clusters carrying rmpA/rmpA2 without extended-spectrum beta-lactamases (ESBL)/carbapenemases produced higher string lengths at 37 °C than at room temperature, and were mostly isolated from the respiratory tract. Other HMV strains showed distinct characteristics of not carrying rmpA/rmpA2 but were positive for ESBL/carbapenemases, with a higher string length at room temperature than at 37 °C, and were frequently isolated from bloodstream infections. In total, 21 (13.5%) HMV isolates carried ESBL and carbapenemases, among which five isolates were carbapenem-resistant hypervirulent Kp with a pLVPK-like plasmid (an epidemic virulence plasmid) and a pKPI-6-like plasmid (an epidemic blaIMP-6-bearing plasmid in Japan), suggesting the convergence of worldwide hypervirulence and epidemic AMR in Japan.",
keywords = "hypermucoviscous, hypervirulent, Klebsiella pneumoniae, multidrug resistance, string test",
author = "Le, {Mi Nguyen Tra} and Shizuo Kayama and Wyres, {Kelly L.} and Liansheng Yu and Junzo Hisatsune and Masato Suzuki and Koji Yahara and Tsuneko Terachi and Kana Sawa and Shin Takahashi and Toshihiko Okuhara and Kunihiko Kohama and Holt, {Kathryn E.} and Tetsu Mizutani and Hiroki Ohge and Motoyuki Sugai",
note = "Funding Information: This study was supported by the Research Program on Emerging and Re-emerging Infectious Diseases from the Japanese Agency for Medical Research and Development (AMED) under grant numbers #20fk0108132j0001 and #21fk0108604j0001, and JSPS KAKENHI Grant Numbers JP21K16947 and JP18K07112. We thank M. Nakazawa, S. Aoki, S. Wakai and E. Anzai (AMR-RC, NIID) for susceptibility testing, T. Ueshimo (Hyogo Prefectural Amagasaki Hospital), H. Nishio (Clinical Laboratory, Shiga Medical Center for Adults, Moriyama, Shiga, Japan), K. Yamasaki (Department of Clinical Laboratory, Wakayama Rosai Hospital, Wakayama, Japan), Y. Wada (Clinical Laboratory, Hyogo Medical University Hospital, Nishinomiya, Hyogo, Japan), S. Kashiyama (Clinical Laboratory, Hiroshima University Hospital, Hiroshima City, Hiroshima, Japan), Y. Koba (Clinical Laboratory, Hiroshima University Hospital, Hiroshima City, Hiroshima, Japan), K. Tadera (National Hospital Organization Kure Medical Center and Chugoku Cancer Center), K. Kimura (Hiroshima City Hiroshima Citizens Hospital), K. Yokota (Hiroshima City Hiroshima Citizens Hospital), M. Shiba (Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital) and T. Harino (Clinical Laboratory, Hiroshima City Asa Hospital, Asakita-ku, Hiroshima City, Hiroshima, Japan) for supplying the Klebsiella isolates, and Y. Sugawara and N. Sakamoto (National Institute of Infectious Diseases) for genome submission to DDBJ. Funding Information: This study was supported by the Research Program on Emerging and Re-emerging Infectious Diseases from the Japanese Agency for Medical Research and Development (AMED) under grant numbers #20fk0108132j0001 and #21fk0108604j0001, and JSPS KAKENHI Grant Numbers JP21K16947 and JP18K07112. Publisher Copyright: {\textcopyright} 2022 The Authors.",
year = "2022",
doi = "10.1099/mgen.0.000827",
language = "English",
volume = "8",
journal = "Microbial Genomics",
issn = "2057-5858",
publisher = "Microbiology Society",
number = "5",
}